OOIR: Observatory of International Research

Papers

(The TQCC of Nature Reviews Nephrology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
A UMOD variant with intermediate effects	624
Mentorship in the lives of scholars	368
Daratumumab for AL amyloidosis	346
Kidney health within the broader non-communicable disease agenda	338
Age-old musings: twenty-first century management of advanced kidney disease in older individuals	306
Making advance care planning easier for adults with kidney disease and their clinicians	302
The GLP-1 receptor agonist revolution comes to nephrology	296
Designing acute kidney injury clinical trials	293
Uropathogen and host responses in pyelonephritis	271
Role of the gut microbiota in the pathogenesis of IgA nephropathy	270
Vaccination in patients with kidney failure: lessons from COVID-19	219
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions	210
Engineered CAR macrophages target kidney inflammation	207
Treatment of chronic kidney disease in older populations	181
Disaster preparedness for patients with kidney disease	175
Genetic determinants of urine and plasma metabolite levels	173
A single-cell atlas of DKD treatment responses	161
Daprodustat for anaemia in CKD	158
Beyond state borders: transforming dialysis care for undocumented immigrants	150
GWAS scorecard prioritizes kidney genes using coding and regulatory variants	145
Roles of sensory receptors in non-sensory organs: the kidney and beyond	145
Transport and barrier mechanisms that regulate ciliary compartmentalization and ciliopathies	140
Non-invasive molecular imaging of kidney diseases	140
Consideration of sex differences is necessary to achieve health equity	138
Complosome — the intracellular complement system	131

Phosphate sensing via PTC glycolysis	128
Mutational signatures of ccRCC vary between geographical regions	126
Bringing Pride to nephrology	125
Reducing preventable acute kidney injury in a hospital setting	123
Publisher Correction: Sustainable Development Goals relevant to kidney health: an update on progress	121
Reference-trial-informed design to explore treatment effects in trial-underrepresented subgroups	119
Clonal haematopoiesis and AKI	118
Increasing diversity and inclusion in nephrology clinical trials	117
The effects of sex hormone therapy on kidney function	116
Interferon blockade in lupus: effects on antiviral immunity	116
Informing clinical decision making during a pandemic — a call for better preparedness	116
Menopause and chronic kidney disease	111
Aquaporin water channels: roles beyond renal water handling	110
The roles of hyaluronan in kidney development, physiology and disease	103
Innovating dialysis through computational modelling of hollow-fibre haemodialysers	101
Benefits of actin cytoskeleton stabilization	101
International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance)	98
Immunometabolic consequences of IL-23	93
From mapping kidney function to mechanism and prediction	93
ERA-EDTA congress 2021	91
NUAK1 promotes kidney fibrosis	90
Identification of erythropoietin-producing cells	90
Design of a renal-sparing antifungal	85
Tertiary lymphoid organs contribute to kidney allograft rejection	84
Treatment of SLE with anti-CD19 CAR-T cells	83
From fat to filter: the effect of adipose tissue-derived signals on kidney function	79
Salt substitution: opportunities and challenges for nephrology	79
Neutrophils and NETs in kidney disease	76
The role of complement in kidney disease	75
Heat and health inequity: acting on determinants of health to promote heat justice	74
RNA-binding proteins and their role in kidney disease	73
Pathological mechanisms of kidney disease in ageing	73
Long-term health outcomes associated with hydration status	73
The evolving landscape of immune-mediated glomerular diseases	67
Reaping the rewards of mechanistic discovery in glomerular disease	64
Author Correction: Chronic cardiovascular–kidney disorder: a new conceptual framework	60
A golden year of innovative kidney disease therapeutics	58
An integrated approach towards a public health perspective on chronic kidney disease	57
A pathway of osmotic stress-induced necroptosis	57
Network medicine: an approach to complex kidney disease phenotypes	56
Drosophila melanogaster: a simple genetic model of kidney structure, function and disease	55
MSC therapy for diabetic kidney disease and nephrotic syndrome	54
Reducing stress-induced CHOP is renoprotective	53
Portable, wearable and implantable artificial kidney systems: needs, opportunities and challenges	52
Patient-centred approaches for the management of unpleasant symptoms in kidney disease	52
Self-reactive innate-like B-1 cells infiltrate grafts	52
Combination therapy for kidney disease in people with diabetes mellitus	52
New insights into the ccRCC microenvironment	51
Consequence of microvascular inflammation in transplantation	51
Ketogenic diet benefits in critically ill patients with sepsis	49

Consequences of famine and malnourishment on kidney health	49
CKD-specific ASCVD risk prediction tools	49
Transcatheter mitral valve repair in patients with CKD	47
The cilia mechanosensation debate gets (bio)physical	47
Educating primary healthcare providers about kidney disease	46
Continuing kidney care in conflicts	46
Kidney complications of parasitic diseases	46
Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function	44
GalNAc-T14-associated defects in B cell homing in IgA nephropathy	44
Role of the cGAS–STING pathway in systemic and organ-specific diseases	44
Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney	44
Mechanism of B cell survival in lupus nephritis	43
Gene therapy in a model of nephrotic syndrome	43
Dietary protection of proximal tubules in diabetes	40
Stem cell–kidney transplantation in Schimke immuno-osseous dysplasia	40
Targeting IL-1Ra to attenuate fungal infection	39
The kidney is a novel target of metformin	38
Nephrology education and training in Africa	38
Multifaceted innovations needed to advance transplant nephrology	37
Mannose as a driver of γδ T cell kidney infiltration	36
Born too soon: lifelong kidney risks and the importance of early intervention	36
Cardiovascular mortality increases with stage of cardiovascular–kidney–metabolic syndrome	34
A guide to gene–disease relationships in nephrology	34
Steps forward in the treatment of IgA nephropathy	34
Chronic cardiovascular–kidney disorder: a new conceptual framework	31
Role of necroptosis in kidney health and disease	31
A multidisciplinary approach to cardiorespiratory fitness in CKD	30
Epithelial cell states associated with kidney and allograft injury	30
Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope	30
Metabolic alterations in hereditary and sporadic renal cell carcinoma	30
ALCAM–CD6 in lupus nephritis	29
Fasting induces structural and functional changes in the peritoneal membrane	29
Derivation of collecting duct organoids	28
Insights into the impact of pregnancy on kidney disease	28
Author Correction: Regulatory T cells in autoimmune kidney diseases and transplantation	27
Author Correction: Therapeutic advances in COVID-19	27
Tissue-resident memory T cells in the urogenital tract	25
Acute kidney injury in patients with burns	25
From big data to smart decisions: artificial intelligence in kidney risk assessment	24
The impact of intrauterine growth restriction and prematurity on nephron endowment	24
The perils of misinformation: when health literacy goes awry	24
Exercise and chronic kidney disease: potential mechanisms underlying the physiological benefits	23
Strategies to achieve gender equity in nephrology	23
Renal nerves in physiology, pathophysiology and interoception	23
Switching off SOX9 for epithelial recovery after AKI	22
Cryo-EM structure of AVP–V2 receptor complex	22
Experimental evidence for a pathogenic role of anti-PLA2R1 antibodies in membranous nephropathy	22
Hope for resistant hypertension through BrigHTN and PRECISION	21
Digital determinants of health: opportunities and risks amidst health inequities	21
CD38 — a new target in renal immune disease	20
Crosstalk between glomeruli and tubules	20
Functional consequences of spatial, temporal and ligand bias of G protein-coupled receptors	20
Collagen formation, function and role in kidney disease	19
The impact of population ageing on the burden of chronic kidney disease	19
Impact of persistent conflict and destabilizing events on dialysis care	19
Chlorthalidone in advanced CKD	18
Nephrology and women’s health post-Roe v. Wade: we must do better	18
The genetics of kidney stone disease and nephrocalcinosis	18
Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup	18
Improving the quality of pharmacoepidemiological studies using the target trial emulation framework	18